Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes

Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes

US Patent 9517228 · Granted Dec 13, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Ultra short acting anti-arrhythmic agents2025
Ultra short acting anti-arrhythmic agents2023
Ultra short acting anti-arrhythmic agents2022
Cannabinoid receptor antagonists/inverse agonists useful for treating disease co2021
Cannabinoid receptor antagonists/inverse agonists useful for treating disease co2021
Ultra short acting anti-arrhythmic agents2020
Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic 2020
Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic 2020
Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic 2018
Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic 2018
Cannabinoid receptor antagonists/inverse agonists useful for treating disease co2015
Cannabinoid receptor antagonists/inverse agonists useful for treating disease co2015